Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Hadi Abbasian
Observed names:
H Abbasian,
Hadi Abbassian
Institution:
Urmia University of Medical Sciences
Observed institutions:
University of Tehran,
Urmia University,
Urmia University of Medical Sciences,
Tehran University of Medical Sciences
ORCID:
0000-0002-0871-9787
Observed ORCID:
0000-0002-0871-9787
OpenAlex ID:
A5066796470
Patient and physician preferences for type 2 diabetes medications: a systematic review
2019
·
Mahdi Toroski
, Abbas Kebriaeezadeh
, et al.
·
Journal of Diabetes & Metabolic Disorders
·
52
Antibiotic utilization in Iran 2000–2016: Pattern analysis and benchmarking with organization for economic co-operation and development Countries
2019
·
Saman Zartab
, Hadi Abbasian
, et al.
·
Journal of Research in Pharmacy Practice
·
52
Post-traumatic stress disorder: a neglected health concern among commercial motor vehicle drivers.
2013
·
H R Saberi
, H Abbasian
, et al.
·
PubMed
·
32
Long-term cost-effectiveness of quality of diabetes care; experiences from private and public diabetes centers in Iran
2022
·
Rahill Sadat Shahtaheri
, Yahya Bayazidi
, et al.
·
Health Economics Review
·
13
PDF
Risk Factors of Supply Chain in Biopharmaceutical Companies in Iran
2020
·
Hadi Abbasian
, Reza Yousefi-Zenouz
, et al.
·
Pharmaceutical Sciences
·
11
PDF
The impact of sanction and healthcare system reform on the healthcare performance and pharmaceutical market in Iran; 2001-2016
2020
·
Saman Zartab
, Nasrin Nassiri Koopaei
, et al.
·
Journal of Pharmaceutical Policy and Practice
·
9
PDF
Assessing drug lag in new drug approvals by the Iran Food and Drug Administration compared to the U.S. FDA, EMA, and PMDA: A 20-year analysis (2001–2021)
2024
·
Sama Alipour
, Sadra Nadimi Parashkouhi
, et al.
·
Medicine
·
6
Risk Assessment for Complex Systems Based on Fuzzy Cognitive Maps: A Case of the Biopharmaceutical Industry
2024
·
Hadi Abbasian
, Reza Yousefi-Zenouz
, et al.
·
Complexity
·
2
Despite Affordability, Low Utilization of Lipid Lowering Drugs in Iran: Trend Analysis and Benchmarking 2005-2016.
2019
·
Saman Zartab
, Hadi Abbassian
, et al.
·
PubMed Central
·
2
PDF
Access to pediatric oncology medicine in Iran: a cross-sectional survey in Urmia
2025
·
Kiana Baghban
, Sadra Nadimi Parashkouhi
, et al.
·
BMC Pediatrics
·
1
PDF
Cost-Utility Analysis of Dose-Dense Methotrexate, Vinblastine, Doxorubicin, and Cisplatin Chemotherapy Regimen in Comparison With Gemcitabine and Cisplatin Chemotherapy Regimen in the Treatment of Patients With Muscle Invasive Bladder Cancer in Iran
2024
·
Sadra Nadimi Parashkouhi
, Iman Karimzadeh
, et al.
·
Value in Health Regional Issues
·
1
PDF
Antidiabetic drug utilization pattern, affordability and cost analysis in Iran from 2009 to 2021: A need to revise guideline
2025
·
Saman Zartab
, Hadi Abbasian
·
PLoS ONE
PDF
Comparison of Hospital Expenditure and Revenue from 6% Hoteling-Eligible Items Over Two Years: A Case Study at Ayatollah Mosavi Zanjan Educational-Medical Center
2024
·
Hamed Ghavimi
, Javad Tajkei
, et al.
·
Journal of Pharmacoeconomics and Pharmaceutical Management
Evaluation of Health Sector in the 5-year Socioeconomic and Cultural Cevelopment Plans of Iran
2023
·
Hadi Abbasian
, Abbas Kebriaeizadeh
, et al.
·
Journal of Pharmacoeconomics and Pharmaceutical Management
Affordability After Subsidy Shift from Parallel Exchange Rate to Insurance: a Retrospective Cross Sectional Study
2023
·
Hadi Abbasian
, Saman Zartab
·
Journal of Pharmacoeconomics and Pharmaceutical Management
Show more works
View as search
Works count:
15
Citation count:
181
H-index:
6
I10-index:
5
Year
Topic
Type